Restricting the expression of the BCR–ABLp190 and BDR–ABLp210 oncogenes in transgenic mice to HSCs, via the Sca1 promotor, leads to human-like B-ALL and CML, respectively [29,30,31]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.